Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             124 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Day 14 Endpoint for Acute GVHD Clinical Trials Spyrou, Nikolaos

4 p. 421-432
artikel
2 Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria Du, Yali

4 p. 301-307
artikel
3 Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source Sterling, Cole H.

4 p. 267.e1-267.e5
artikel
4 Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia Mizuno, Shohei

4 p. 314.e1-314.e10
artikel
5 Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children Klimentova, Maria

4 p. 437.e1-437.e11
artikel
6 American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients Neofytos, Dionysios

4 p. 222-227
artikel
7 A More MAGICal Alogrithm in Acute GVHD Hong, Sanghee

4 p. 347-348
artikel
8 An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Tokaz, Molly C.

4 p. 279.e1-279.e10
artikel
9 A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis Kim, Haryoon

4 p. 419.e1-419.e12
artikel
10 An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation Jeurkar, Chetan

4 p. 327.e1-327.e11
artikel
11 An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT Haynes, Andrew S.

4 p. 317-326
artikel
12 Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation Huang, Alice

4 p. 214.e1-214.e11
artikel
13 A Positive Psychology Intervention for Caregivers of Hematopoietic Stem Cell Transplantation Survivors (PATH-C): Initial Testing and Single-Arm Pilot Trial Amonoo, Hermioni L.

4 p. 448.e1-448.e14
artikel
14 A Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Zhang, Ao-Bei

4 p. 240.e1-240.e10
artikel
15 A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD) Mupfudze, Tatenda G.

4 p. 345-351
artikel
16 Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation Bognàr, Tim

4 p. 196-202
artikel
17 ASTCT Notes
4 p. 219
artikel
18 ASTCT Notes
4 p. 353
artikel
19 Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience Pasvolsky, Oren

4 p. 260.e1-260.e6
artikel
20 Body Weight Loss Before Allogeneic Hematopoietic Stem Cell Transplantation Predicts Survival Outcomes in Acute Leukemia Patients Tamaki, Masaharu

4 p. 340.e1-340.e6
artikel
21 Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy Hubbeling, Harper

4 p. 259.e1-259.e10
artikel
22 Building a Transplant Center: From the Karolinska to Kathmandu Ringden, Olle

4 p. 339-343
artikel
23 Characterizing Immune-Mediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation for Pediatric Nonmalignant Disorders Galvin, Robert T.

4 p. 316.e1-316.e8
artikel
24 Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival Vigorito, Afonso Celso

4 p. 276.e1-276.e7
artikel
25 Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model Nakamura, Naokazu

4 p. 404-414
artikel
26 Commentary: Is Immune Recovery-Based Post-Transplantation Vaccination in Children Better Than Time-Based Revaccination? Carpenter, Paul A.

4 p. 281-283
artikel
27 Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Dhawale, Tejaswini

4 p. 402.e1-402.e12
artikel
28 Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Hong, Sanghee

4 p. 217.e1-217.e6
artikel
29 Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive Therapy Miyao, Kotaro

4 p. 342.e1-342.e10
artikel
30 Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion Koster, Eva A.S.

4 p. 268.e1-268.e10
artikel
31 Cord Blood-Derived Multipotent Stem Cells Ameliorate in Vitro/in Vivo Alloreactive Responses, and This Effect Is Associated with Exosomal Microvesicles in Vitro Descalzi-Montoya, Dante B.

4 p. 396.e1-396.e14
artikel
32 Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma Hashmi, Hamza

4 p. 262.e1-262.e6
artikel
33 Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes Rashid, Nahid

4 p. 417.e1-417.e9
artikel
34 Discharge Disposition Following Hematopoietic Cell Transplantation: Predicting the Need for Rehabilitation and Association with Survival Wall, Sarah A.

4 p. 337.e1-337.e7
artikel
35 Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma Merino, Aimee M.

4 p. 310.e1-310.e6
artikel
36 Early-Phase Peripheral Blood Eosinophilia Predicts Lower Overall and Non-Relapse Mortality After Single-Unit Cord Blood Transplantation Konuma, Takaaki

4 p. 336.e1-336.e9
artikel
37 Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease Prophylaxis Oshrine, Benjamin

4 p. 203.e1-203.e7
artikel
38 Editorial Board
4 p. A7
artikel
39 Editorial Board
4 p. A5
artikel
40 Editorial Board
4 p. A6
artikel
41 Editorial Board
4 p. A10
artikel
42 Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell Transplantation Liu, Yin

4 p. 332.e1-332.e8
artikel
43 Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials Krishnamurti, Lakshmanan

4 p. 217-221
artikel
44 Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia Alsaggaf, Rotana

4 p. 313.e1-313.e8
artikel
45 Ethical Challenges in CAR-T slot allocation Faiman, Beth

4 p. 215-216
artikel
46 Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience Kourelis, Taxiarchis

4 p. 255-258
artikel
47 Factors Affecting Day-to-Day Variations in Tacrolimus Concentration among Children and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Maruyama, Yuta

4 p. 270.e1-270.e8
artikel
48 Family-Focused Facilitated Fitness: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Their Caregiving Partners Langer, Shelby L.

4 p. 450.e1-450.e17
artikel
49 Gaps in Medicaid Coverage and Financial Toxicity: A Health Disparity in Hematopoietic Cell Transplantation for Sickle Cell Disease Krishnamurti, Lakshmanan

4 p. 284-285
artikel
50 Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation: From Graft-versus-Host Disease to the Graft-versus-Tumor Effect Bernardi, Chiara

4 p. 386-395
artikel
51 Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia Metheny, Leland

4 p. 286-291
artikel
52 Haploidentical Transplantation with Modified Post-transplantation Cyclophosphamide for Patients with Primary Aplastic Anemia: A Multicenter Experience Li, Yun

4 p. 331.e1-331.e7
artikel
53 High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation Sumransub, Nuttavut

4 p. 184.e1-184.e8
artikel
54 Home-Based Hematopoietic Cell Transplantation in the United States Sung, Anthony D.

4 p. 207.e1-207.e8
artikel
55 Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis Gabanti, Elisa

4 p. 211.e1-211.e9
artikel
56 Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort Glushkova, Svetlana

4 p. 435.e1-435.e12
artikel
57 Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults Sugidono, Matthew

4 p. 344.e1-344.e5
artikel
58 Improved Accessibility of Optimally Matched Stem Cell Donors Fleischhauer, Katharina

4 p. 213-214
artikel
59 International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update Rotz, Seth J.

4 p. 349-385
artikel
60 Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases Cattoni, Alessandro

4 p. 271.e1-271.e12
artikel
61 Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study Saglio, Francesco

4 p. 433.e1-433.e10
artikel
62 Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients Einarsdottir, Sigrun

4 p. 275.e1-275.e5
artikel
63 Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study Rodríguez-Arbolí, Eduardo

4 p. 311.e1-311.e10
artikel
64 Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma Afrough, Aimaz

4 p. 264.e1-264.e9
artikel
65 Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation Kuwatsuka, Yachiyo

4 p. 444.e1-444.e11
artikel
66 Masthead (Purpose and Scope)
4 p. A6
artikel
67 Masthead (Purpose and Scope)
4 p. A4
artikel
68 Masthead (Purpose and Scope)
4 p. A5
artikel
69 Masthead (Purpose and Scope)
4 p. A9
artikel
70 Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model Shi, Chunyu

4 p. 398.e1-398.e10
artikel
71 Mature Naive B Cells Regulate the Outcome of Murine Acute Graft-versus-Host Disease in an IL-10-Independent Manner Galvani, Rômulo Gonçalves

4 p. 181.e1-181.e9
artikel
72 Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation Ruggeri, Loredana

4 p. 206.e1-206.e6
artikel
73 Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas Castagna, Luca

4 p. 328.e1-328.e6
artikel
74 Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T Akinola, Idayat M.

4 p. 254.e1-254.e9
artikel
75 N-Acetyl-L-Cysteine Potentially Inhibits Complement Activation in Transplantation-Associated Thrombotic Microangiopathy Qi, Jiaqian

4 p. 216.e1-216.e5
artikel
76 Non-Graft-versus-Host Disease Enterocolitis Following Cord Blood Transplantation is Real, with Poorly Understood Pathophysiology, and Requires Distinct Management, with Eventual Resolution without Immune Suppression Horgan, Claire

4 p. 440.e1-440.e9
artikel
77 Officers and Directors of ASTCT
4 p. A8
artikel
78 Officers and Directors of ASTCT
4 p. A6
artikel
79 Officers and Directors of ASTCT
4 p. A7
artikel
80 Officers and Directors of ASTCT
4 p. A11
artikel
81 Optimal Timing of Allogeneic Stem Cell Transplantation for Primary Myelofibrosis Cipkar, Christopher

4 p. 189-194
artikel
82 Outcomes After Donor Lymphocyte Infusion in Patients With Hematological Malignancies: Donor Characteristics Matter Ros-Soto, Jose

4 p. 183.e1-183.e8
artikel
83 Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation Mirza, Abu-Sayeef

4 p. 185.e1-185.e7
artikel
84 Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy Perl, Alexander E.

4 p. 265.e1-265.e10
artikel
85 Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research Murthy, Hemant S.

4 p. 187.e1-187.e10
artikel
86 Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies Nikiforow, Sarah

4 p. 228-239
artikel
87 Pediatric Hematopoietic Stem Cell Transplantation: Challenges in Small European Countries Rascon, Jelena

4 p. 269.e1-269.e10
artikel
88 Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types Kaida, Katsuji

4 p. 273.e1-273.e9
artikel
89 Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma Yoon, Dok Hyun

4 p. 253.e1-253.e9
artikel
90 Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study Dovern, Elisabeth

4 p. 283.e1-283.e9
artikel
91 Picture Perfect Predictive Model: Does it Exist? Sainatham, Chiranjeevi

4 p. 344-346
artikel
92 Plasma Levels of MRP-8/14 Associate With Neutrophil Recovery, Bacterial Bloodstream Infections, and Engraftment Syndrome Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Kammersgaard, Marte B.

4 p. 242.e1-242.e9
artikel
93 Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy Lee, Dasom

4 p. 277.e1-277.e9
artikel
94 Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC Bailén, Rebeca

4 p. 204.e1-204.e10
artikel
95 Post-Transplantation Cyclophosphamide-Based Haploidentical versus Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia Hong, Kyung Taek

4 p. 195.e1-195.e7
artikel
96 Post-Traumatic Stress Symptoms in Hematopoietic Stem Cell Transplant Recipients Fenech, Alyssa L.

4 p. 341.e1-341.e6
artikel
97 Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients Sung, Anthony D.

4 p. 415.e1-415.e16
artikel
98 Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio Miyazaki, Takuya

4 p. 400.e1-400.e9
artikel
99 Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study Li, Ang

4 p. 308.e1-308.e8
artikel
100 Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma Parmar, Harsh

4 p. 309.e1-309.e5
artikel
101 Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy Barata, Anna

4 p. 452.e1-452.e11
artikel
102 Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis Puckrin, Robert

4 p. 218.e1-218.e4
artikel
103 Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report Bankova, Andriyana K.

4 p. 215.e1-215.e10
artikel
104 Reduced Cytokine Release Syndrome and Improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell Transplantation Tang, Jerrica

4 p. 438.e1-438.e11
artikel
105 Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group Kimura, Shun-ichi

4 p. 209.e1-209.e9
artikel
106 Risk of Cytomegalovirus Infection with Post-Transplantation Cyclophosphamide in Haploidentical and HLA-Matched Unrelated Donor Transplantation Jamy, Omer

4 p. 213.e1-213.e6
artikel
107 Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation Sumransub, Nuttavut

4 p. 263.e1-263.e7
artikel
108 Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy Bansal, Radhika

4 p. 455.e1-455.e7
artikel
109 Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study Seftel, Matthew D.

4 p. 352.e1-352.e5
artikel
110 Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell–Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia Shelikhova, Larisa

4 p. 330.e1-330.e9
artikel
111 Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission Konuma, Takaaki

4 p. 334.e1-334.e11
artikel
112 Sinusoidal Obstruction Syndrome in Critically Ill Patients in the Era of Defibrotide: A Retrospective Multicenter Study Debureaux, Pierre-Edouard

4 p. 338.e1-338.e7
artikel
113 Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study Bulthuis, Marjolein S.

4 p. 446.e1-446.e11
artikel
114 Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy Dandoy, Christopher E.

4 p. 282.e1-282.e9
artikel
115 Table of Contents
4 p. A17-A20
artikel
116 Table of Contents
4 p. A7-A11
artikel
117 Table of Contents
4 p. A8-A13
artikel
118 Table of Contents
4 p. A12-A15
artikel
119 TIMING IS EVERYTHING: When IS the Time Right for Transplant in Myelofibrosis Therapy? Gowin, Krisstina

4 p. 177-178
artikel
120 Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients Schwenk, Hayden T.

4 p. 292-300
artikel
121 Unrelated Stem Cell Donor HLA Match Likelihood in the US Registry Incorporating HLA-DPB1 Permissive Mismatching Gragert, Loren

4 p. 244-252
artikel
122 Upfront Umbilical Cord Blood Transplantation Versus Immunosuppressive Therapy for Pediatric Patients With Idiopathic Severe Aplastic Anemia Zhao, Xuxu

4 p. 442.e1-442.e13
artikel
123 Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults Ramos, Kristie N.

4 p. 454.e1-454.e6
artikel
124 VOD/SOS and Alkylating Agents in the Hematopoietic Stem Cell Transplant Setting: New Insights and Further Questions Myers, Alan L.

4 p. 179-180
artikel
                             124 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland